Year None202320222021202020192018201720162015 Kezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia September 20, 2023 at 6:30 PM EDT Kezar Life Sciences to Participate in Three Upcoming Investor Conferences August 31, 2023 at 4:01 PM EDT Kezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update August 10, 2023 at 4:01 PM EDT Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) August 4, 2023 at 4:03 PM EDT Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) July 7, 2023 at 4:01 PM EDT Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) June 9, 2023 at 4:01 PM EDT Kezar Life Sciences to Participate in the Jefferies Healthcare Conference May 31, 2023 at 7:00 AM EDT Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update May 11, 2023 at 4:01 PM EDT Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) April 5, 2023 at 4:01 PM EDT Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update March 14, 2023 at 4:01 PM EDT Pagination Current page 1 Page 2 Next page next › Last page last »
Kezar Life Sciences and Everest Medicines Enter into an Agreement to Develop and Commercialize Zetomipzomib for Lupus Nephritis and other Potential Indications in Greater China, South Korea and Southeast Asia September 20, 2023 at 6:30 PM EDT
Kezar Life Sciences to Participate in Three Upcoming Investor Conferences August 31, 2023 at 4:01 PM EDT
Kezar Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update August 10, 2023 at 4:01 PM EDT
Kezar Life Sciences to Participate in the Jefferies Healthcare Conference May 31, 2023 at 7:00 AM EDT
Kezar Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update May 11, 2023 at 4:01 PM EDT
Kezar Life Sciences Reports Fourth Quarter and Year End 2022 Financial Results and Provides Business Update March 14, 2023 at 4:01 PM EDT